Selective Reduction of Central Pulse Pressure Under Angiotensin Blockage in SHR: Role of the Fibronectin- 5 1 Integrin Complex
Author(s) -
Augustine Kakou,
Yvonnick Bézie,
Nathalie Mercier,
Huguette Louis,
Carlos Labat,
P. Challande,
P. Lacolley,
M. E. Safar
Publication year - 2009
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2009.87
Subject(s) - medicine , pulse pressure , integrin , fibronectin , angiotensin ii , blood pressure , reduction (mathematics) , renin–angiotensin system , pulse (music) , endocrinology , microbiology and biotechnology , cardiology , receptor , extracellular matrix , biology , geometry , mathematics , engineering , detector , electrical engineering
Meta-analyses of antihypertensive therapy suggest that, independently of blood pressure (BP) level, stroke prevention is influenced mainly by calcium-entry blockers (CEB) and cardiac risk prevention by angiotensin-converting enzyme inhibitors (ACEIs). The possibility that central systolic and pulse pressure (PP) reduction differs between the two drug classes for the same mean BP (MBP) has never been explored. Our aim was to compare carotid PP at the same MBP obtained with the CEB, amlodipine, and the ACEI, trandolapril, in spontaneously hypertensive rats (SHR), and to evaluate the resulting changes of fibronectin (Fn) and its integrin alpha5beta1 receptor on central PP and arterial stiffness.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom